Stock screenerAll disclosures →
EDGAR →
PCSA
Conviction 27HealthcareScan · Thu, Jun 25, 2026PCSA$1.90-1.55%
ResistanceSupportVol 14Insider buy5
5
7
7
Vol MA14 66.33K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.90
Change-1.55%
Gap+0.52%
Rel volume0.45×
Avg volume67.98K
Avg $ vol157.92K
SMA 202.31
SMA 502.59
SMA 2001.89
Price vs 50-26.51%
Price vs 200+0.29%
MA stackmixed
50/200 cross—
Supertrenddown · 2.63
RSI (14)36
MACD hist-0.03
MACD cross—
Stoch %K / %D2 / 5
ADX (14)21
+DI / −DI12 / 24
RSI divergence—
MACD divergence—
ATR %+13.46%
ADR %11.73%
52w high6.68
52w low0.1202
From 52w high-71.56%
Above 52w low+1480.70%
New 52w highNo
SqueezeOff
Bollinger width52.80%
%B0.16
Donchian pos1.79%
Donchian high3.00
Donchian low1.88
AVWAP (52w high)5.53
vs AVWAP high-65.66%
AVWAP (52w low)4.78
vs AVWAP low-60.26%
OBV trendDown
Chaikin MF (20)-0.18
Today vs 20d0.45×
Avg vol (14d)66.33K
Avg vol (20d)67.98K
Avg $ vol (20d)157.92K
Market cap5.23M
RS 3m (vs SPY)-29.42%
RS 6m (vs SPY)-56.68%
RS line new highNo
Trend template4/8
Technical rank18.9
1 week-11.63%
1 month-24.00%
3 months-17.39%
6 months-47.22%
1 year+557.21%
YTD-35.15%
P/E-0.39
P/B2.06
P/S—
P/FCF-0.46
EPS-10.36
Div yield0.82%
ROE-533.82%
ROA-300.02%
Debt/Eq0.10
Current0.98
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-14.46%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value3.79M
Revenue0
Net income-3.38M
Gross profit5K
Free cash flow-11.39M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees12
ListedMon, Oct 7, 2013
Free float1.91M
Float %84.4%
Short interest91.06K
Days to cover1.6d
Short volume23.1%
Squeeze score18 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank18.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.19
Support1.96
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PCSA
No recent disclosed trades by Congress in PCSA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PCSA · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Guy Wendy Chief Administrative Officer · Common Stock · 2026-05-29 | Buy | 1.83K | $5K | 2026-05-29 | 2026-06-01 |
Young David Pres. Research & Development · Common Stock · 2026-05-29 | Buy | 1.79K | $5K | 2026-05-29 | 2026-06-01 |
Lin Patrick Chief Business - Strategy Off · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-01 |
Lin Patrick Chief Business - Strategy Off · Common Stock · 2026-05-29 | Buy | 1.58K | $4K | 2026-05-29 | 2026-06-01 |
Young David Pres. Research & Development · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-01 |
Ng George K Chief Executive Officer · Common Stock · 2026-05-29 | Buy | 2.13K | $5K | 2026-05-29 | 2026-06-01 |
SKIBSTED RUSSELL Chief Financial Officer · Common Stock · 2026-05-29 | Buy | 2.29K | $6K | 2026-05-29 | 2026-06-01 |
Guy Wendy Chief Administrative Officer · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-01 |
Ng George K Chief Executive Officer · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-01 |
Ng George K Chief Executive Officer · Common Stock · 2026-05-15 | Buy | 1.84K | $5K | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in PCSA · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.